WIN 2017 Symposium: 26 and 27 June, in Paris
Expediting Global Innovation in Precision Cancer Medicine

If you want to:

1. Be part of developing tomorrow’s Precision Oncology and bring your expertise in open forums with world class oncology leaders
2. Hear the latest developments from outstanding speakers from academia and industry
3. Participate in a satellite symposium with Roche-Foundation Medicine
4. Network with guest speakers and WIN Consortium members

Then join us, because your vision and opinion matters. Register now!

The goal of the WIN 2017 Symposium is to speed up the application of science to the development of effective cancer treatments in an exceptional program with the following session themes:

• Innovation in clinical trial design
• New avenues for target discovery
• Immunological approach to personalized medicine
• Next great steps in cancer therapy
• Predict: what and how?
• Using new knowledge in clinical trials

This symposium assembles all stakeholders in cancer care, from academia and industry, to cancer research institutions and patient advocacy organizations.
 
No other event, gives you more focused expertise from getting science to the clinic and the possibility of exchanging ideas in open forums and a round table discussion.

• New trends in clinical trial design, moderated by Razelle Kurzrock (UCSD) and Brian Leyland-Jones (Avera Cancer Institute)
• Place of immunotherapy approaches in precision cancer care, moderated by Antoni Ribas (UCLA) and Jean-Yves Blay (Centre Léon Bérard)
• Challenges of real world implementation of precision medicine and implications for other diseases, moderated by Lisa Hutchinson (Nature Publishing Group) and Thomas Tursz (Fondation ARC) with the exceptional participation of Richard L. Schilsky (ASCO^®), Martine J. Piccart-Gebhart (Institute Jules Bordet), Francesco De Lorenzo (European Cancer Patient Coalition) and Andrea Califano (Columbia University)